Ras-MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells. [electronic resource]
Producer: 20170801Description: 694-704 p. digitalISSN:- 1538-8514
- Animals
- Bone Neoplasms -- drug therapy
- Breast Neoplasms -- genetics
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Checkpoint Kinase 1 -- genetics
- DNA Damage
- Deoxycytidine -- administration & dosage
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Heterocyclic Compounds, 3-Ring -- administration & dosage
- Humans
- MAP Kinase Signaling System -- drug effects
- Mice
- Osteosarcoma -- drug therapy
- Ovarian Neoplasms -- genetics
- Piperidines -- administration & dosage
- Proto-Oncogene Proteins p21(ras) -- genetics
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.